Heart disease risk assessment tools specific to women remain lacking, despite the fact cardiovascular disease is the leading cause of mortality in women.
QuidelOrtho test could miss heart attacks, drawing Class I recall
Dive Brief: QuidelOrtho’s recall of a test to detect heart attacks was labeled Class I by the Food and Drug Administration, the most serious type
July 17, 2023